HUP0102540A2 - Novel angiotensin receptor, production and use thereof - Google Patents

Novel angiotensin receptor, production and use thereof

Info

Publication number
HUP0102540A2
HUP0102540A2 HU0102540A HUP0102540A HUP0102540A2 HU P0102540 A2 HUP0102540 A2 HU P0102540A2 HU 0102540 A HU0102540 A HU 0102540A HU P0102540 A HUP0102540 A HU P0102540A HU P0102540 A2 HUP0102540 A2 HU P0102540A2
Authority
HU
Hungary
Prior art keywords
receptor
production
angiotensin receptor
nucleic acid
novel angiotensin
Prior art date
Application number
HU0102540A
Other languages
Hungarian (hu)
Inventor
Holger Heitsch
Jörg-Peter Kleim
Günter Riess
Gertrud Sibenhorn
Original Assignee
Aventis Pharma Deutschland Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh. filed Critical Aventis Pharma Deutschland Gmbh.
Publication of HUP0102540A2 publication Critical patent/HUP0102540A2/en
Publication of HUP0102540A3 publication Critical patent/HUP0102540A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Abstract

A találmány olyan új angiotenzin-receptorra vonatkozik, amely legalábbegy a 10. szekvencia szerinti aminosav-szekvenciával rendelkezőegységet tartalmaz. A találmány továbbá a receptort kódoló nukleinsav,valamint a receptor előállítására szolgáló eljárásra, a nukleinsav ésa receptor alkalmazására, továbbá a nukleinsavat tartalmazógyógyszerkészítményekre vonatkozik. ÓThe invention relates to a new angiotensin receptor that contains at least one unit with the amino acid sequence of sequence 10. The invention also relates to the nucleic acid encoding the receptor, as well as to the process for producing the receptor, the use of the nucleic acid and the receptor, and also to pharmaceutical preparations containing the nucleic acid. HE

HU0102540A 1998-06-08 1999-05-12 Novel angiotensin receptor, production and use thereof HUP0102540A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19825494A DE19825494A1 (en) 1998-06-08 1998-06-08 New angiotensin receptor, production and use of the same
PCT/EP1999/003249 WO1999064585A2 (en) 1998-06-08 1999-05-12 Novel angiotensin receptor, production and use thereof

Publications (2)

Publication Number Publication Date
HUP0102540A2 true HUP0102540A2 (en) 2001-10-28
HUP0102540A3 HUP0102540A3 (en) 2003-09-29

Family

ID=7870244

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102540A HUP0102540A3 (en) 1998-06-08 1999-05-12 Novel angiotensin receptor, production and use thereof

Country Status (14)

Country Link
EP (1) EP1086217A2 (en)
JP (1) JP2002517237A (en)
KR (1) KR20010052703A (en)
CN (1) CN1304449A (en)
AR (1) AR020086A1 (en)
AU (1) AU4361699A (en)
BR (1) BR9912183A (en)
CA (1) CA2330229A1 (en)
DE (1) DE19825494A1 (en)
HU (1) HUP0102540A3 (en)
ID (1) ID27566A (en)
PL (1) PL345949A1 (en)
TR (1) TR200003662T2 (en)
WO (1) WO1999064585A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7176261B2 (en) * 2004-10-21 2007-02-13 Medtronic, Inc. Angiotensin-(1-7) eluting polymer-coated medical device to reduce restenosis and improve endothelial cell function

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0647239A4 (en) * 1992-06-24 1997-07-02 Univ Washington Angiotensin iv peptides and receptor.

Also Published As

Publication number Publication date
EP1086217A2 (en) 2001-03-28
WO1999064585A2 (en) 1999-12-16
CN1304449A (en) 2001-07-18
TR200003662T2 (en) 2001-07-23
BR9912183A (en) 2001-04-10
DE19825494A1 (en) 1999-12-09
CA2330229A1 (en) 1999-12-16
WO1999064585A3 (en) 2000-04-06
JP2002517237A (en) 2002-06-18
ID27566A (en) 2001-04-12
AR020086A1 (en) 2002-04-10
AU4361699A (en) 1999-12-30
HUP0102540A3 (en) 2003-09-29
PL345949A1 (en) 2002-01-14
KR20010052703A (en) 2001-06-25

Similar Documents

Publication Publication Date Title
ID26207A (en) SUBSTITUTED ESTRATRIENA 11β-HALOGEN-7 αTERSUBSTITUTATION, PROCESS FOR PRODUCING PHARMACEUTICAL PROPERTIES CONTAINING ESTRATRIENA 11β-HALOGEN-7 αINII AND ALSO USE FOR PHARMACEUTICAL PRODUCTION CONTAINING
MXPA02004666A (en) Recombinant gelatins.
FI962247A (en) Novel apoptosis-transforming proteins, DNA encoding them, and methods for their use
DK0859766T3 (en) Chiral methylphenyloxazolidinones
SE9802729D0 (en) Novel Compounds
DE60202958D1 (en) STABLE POLYMORPH OF FLIBANSERIN, INDUSTRIAL PROCESS FOR THE PRODUCTION THEREOF AND ITS USE FOR THE PRODUCTION OF MEDICAMENTS
DE69426033T2 (en) DNA ENCODING THE ALPHA-1E UNIT OF THE HUMAN CALCIUM CHANNEL
SE9903291D0 (en) New process
PL336640A1 (en) Substituted 3,3-diamino-2- propenonitriles, their production and application
TR200000697T2 (en) Substituted 1,2,3,4,5,6-Hexahydro-2,6-Methano-3-Benzazosin-10-OLs, production methods and their use as pharmaceutical preparations.
EP0546087A4 (en)
DK0793721T3 (en) Peptides capable of binding to the SH3 domain of the GAP protein, nucleotide sequences encoding therefore, production and use thereof
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
DE69808475D1 (en) AMINO ACID DERIVATIVES FOR TREATING STROKE
MXPA04004090A (en) Substituted 1h-quinolin-2-one compounds.
HUP0102540A2 (en) Novel angiotensin receptor, production and use thereof
HUP0100802A2 (en) Pharmaceutical compositions comprising (1s,4r)-cis-4[2-amino-6-(cyclopropyl-amino)-9h-purin-9-yl]-2-cyclopentene-1-methanol
PT1246790E (en) 1- AND 2-NAFTOL REPLACED MANNICH BASES
FR2771737B1 (en) PROCESSES FOR THE PRODUCTION AND PURIFICATION OF 1,1-DIFLUOROETHANE AND PRODUCT THUS OBTAINED
SE9800865D0 (en) New Process
ATE331733T1 (en) METAL-CONTAINING RIBONUCLEOTIDE POLYPEPTIDES
HUP0004739A1 (en) Nucleic acids coding for proteins capable of interacting with presenilins
SE9704834D0 (en) New process
CO5150221A1 (en) NEW 3-PHENOXI- AND 3-PHENYLALQUILOXI-2-PHENYL-SUBSTITUTED PROPILAMINS
MX9704836A (en) Process for the manufacture of acetonylbenzamides.